Come up with a name for your new list and we'll add to it:
Goldfinch Bio raised a round of funding on December 14, 2016. Investors include
Third Rock Ventures.
Goldfinch is singularly focused on discovering and developing precision therapies for patients with kidney disease. Recent breakthroughs in genetics and biology have generated an unparalleled understa…